Anesth Pain Med.  2024 Jan;19(1):1-4. 10.17085/apm.24008.

A message from the Editor-in-Chief and Editorial Board, 2023: journal metrics and statistics, and appreciation to reviewers

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea
  • 2Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea


Figure

  • Fig. 1. Number of articles submitted to Anesthesiology and Pain Medicine in 2021, 2022, and 2023 according to the author's country.


Reference

1. Kang H. Trial sequential analysis: novel approach for meta-analysis. Anesth Pain Med (Seoul). 2021; 16:138–50.
Article
2. Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul). 2022; 17:1–11.
Article
3. Lee TY, Jeong SY, Jeong JH, Kim JH, Choi SR. Comparison of postoperative pulmonary complications between sugammadex and neostigmine in lung cancer patients undergoing video-assisted thoracoscopic lobectomy: a prospective double-blinded randomized trial. Anesth Pain Med (Seoul). 2021; 16:60–7.
Article
Full Text Links
  • APM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr